Linda

Years of writing advocacy legal briefs using selective quotes from myriad sources show up in my hopscotching around articles, studies, etc in my posts. I'm not sure which of these three sources you want but here goes
My first post excerpted the comments of a Dr. Jimeno from a Sat, Oct 15, 2011OCF news article :Locoregional recurrence of an HPV-positive squamous cell carcinoma of the head and neck that came from www.cancernetwork.com . Dr Jimeno cited two studies in support of his points One by Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128-37. The other by Koutcher L, Sherman E, Fury M, et al. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 13. [Epub ahead of print]
Later in the thread, I excerpted a Tue, Oct 18, 2011 OCF news article (that one has a blue hyper link to it) to quote D. Neil Hayes, MD, MPH, of the University of North Carolina at Chapel Hill. He described efforts to position the epidermal growth factor receptor (EGFR) inhibitor cetuximab (Erbitux) in head and neck cancer treatment. The study he referenced was the phase�III Radiation Therapy Oncology Group (RTOG) 0522 trial .
Finally, I cut and pasted from American College of Radiology ACR Appropriateness Criteria� ADJUVANT THERAPY FOR RESECTED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
All three of these came to my attention thru the OCF News Feed. I recommend reading it daily. It's easy to add to Google news and other RSS readers or you can just go to the OCF News pages directly.
As I mentioned, many times the actual article is locked behind a "Pay Wall" so without OCF news, I would probably never know about so many important developments.
Hope this helps
Charm